Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.48 USD | -1.47% |
|
+1.30% | +3.75% |
07-15 | Benchmark Adjusts CSX Price Target to $37 From $35, Maintains Buy Rating | MT |
07-15 | Raymond James Adjusts CSX Price Target to $37 From $33, Maintains Outperform Rating | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.07 | 8.13 | 8.93 | 8.24 | 7.97 | |||||
Return on Total Capital | 9.35 | 10.75 | 11.92 | 11.08 | 10.77 | |||||
Return On Equity % | 22.14 | 28.42 | 31.89 | 30.01 | 28.34 | |||||
Return on Common Equity | 22.17 | 28.44 | 31.92 | 30.03 | 28.35 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 54.76 | 53.05 | 49.75 | 48.91 | 48.65 | |||||
EBITDA Margin % | 54.76 | 53.05 | 49.75 | 48.91 | 48.65 | |||||
EBITA Margin % | 41.69 | 41.71 | 39.72 | 37.99 | 37.33 | |||||
EBIT Margin % | 41.69 | 41.71 | 39.66 | 37.92 | 37.25 | |||||
Income From Continuing Operations Margin % | 26.13 | 30.19 | 28.05 | 25.35 | 23.87 | |||||
Net Income Margin % | 26.13 | 30.19 | 28.05 | 25.35 | 23.87 | |||||
Net Avail. For Common Margin % | 26.13 | 30.19 | 28.05 | 25.35 | 23.87 | |||||
Normalized Net Income Margin | 21.75 | 22.54 | 21.89 | 20.72 | 20.1 | |||||
Levered Free Cash Flow Margin | 17.11 | 21.7 | 18.29 | 17.19 | 14.73 | |||||
Unlevered Free Cash Flow Margin | 21.56 | 25.3 | 21.41 | 20.64 | 18.31 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.27 | 0.31 | 0.36 | 0.35 | 0.34 | |||||
Fixed Assets Turnover | 0.32 | 0.38 | 0.44 | 0.42 | 0.41 | |||||
Receivables Turnover (Average Receivables) | 11.15 | 12.16 | 12.07 | 10.83 | 10.7 | |||||
Inventory Turnover (Average Inventory) | 17.01 | 18.34 | 21.95 | 19.03 | 17.48 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.2 | 1.73 | 1.56 | 1.05 | 0.86 | |||||
Quick Ratio | 2 | 1.55 | 1.38 | 0.88 | 0.71 | |||||
Operating Cash Flow to Current Liabilities | 2.11 | 2.28 | 2.27 | 1.72 | 1.6 | |||||
Days Sales Outstanding (Average Receivables) | 32.82 | 30.02 | 30.24 | 33.69 | 34.22 | |||||
Days Outstanding Inventory (Average Inventory) | 21.52 | 19.9 | 16.63 | 19.18 | 20.93 | |||||
Average Days Payable Outstanding | 70.18 | 54.66 | 51.17 | 56.89 | 62.16 | |||||
Cash Conversion Cycle (Average Days) | -15.85 | -4.74 | -4.3 | -4.02 | -7 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 131.24 | 125.24 | 148.29 | 158.24 | 153.39 | |||||
Total Debt / Total Capital | 56.75 | 55.6 | 59.72 | 61.28 | 60.54 | |||||
LT Debt/Equity | 127.83 | 123.43 | 146.55 | 153.08 | 147.97 | |||||
Long-Term Debt / Total Capital | 55.28 | 54.8 | 59.02 | 59.28 | 58.39 | |||||
Total Liabilities / Total Assets | 67.05 | 66.69 | 69.88 | 71.39 | 70.75 | |||||
EBIT / Interest Expense | 5.85 | 7.23 | 7.94 | 6.87 | 6.51 | |||||
EBITDA / Interest Expense | 7.79 | 9.32 | 10.11 | 9 | 8.64 | |||||
(EBITDA - Capex) / Interest Expense | 5.64 | 6.84 | 7.23 | 6.18 | 5.6 | |||||
Total Debt / EBITDA | 2.93 | 2.51 | 2.5 | 2.64 | 2.67 | |||||
Net Debt / EBITDA | 2.39 | 2.17 | 2.22 | 2.44 | 2.53 | |||||
Total Debt / (EBITDA - Capex) | 4.05 | 3.42 | 3.49 | 3.84 | 4.12 | |||||
Net Debt / (EBITDA - Capex) | 3.31 | 2.95 | 3.1 | 3.55 | 3.9 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -11.34 | 18.32 | 18.62 | -1.32 | -0.8 | |||||
Gross Profit, 1 Yr. Growth % | -9.16 | 15.33 | 11.08 | -2.99 | -0.41 | |||||
EBITDA, 1 Yr. Growth % | -9.16 | 15.33 | 11.08 | -2.99 | -0.41 | |||||
EBITA, 1 Yr. Growth % | -12.29 | 19.33 | 12.64 | -5.63 | -1.42 | |||||
EBIT, 1 Yr. Growth % | -12.29 | 19.33 | 12.55 | -5.64 | -1.46 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -16.99 | 36.74 | 10.18 | -10.83 | -5.4 | |||||
Net Income, 1 Yr. Growth % | -16.99 | 36.74 | 10.18 | -10.83 | -5.4 | |||||
Normalized Net Income, 1 Yr. Growth % | -15.29 | 23.79 | 14.94 | -6.59 | -2.52 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -13.67 | 40 | 16.07 | -5.13 | -1.67 | |||||
Accounts Receivable, 1 Yr. Growth % | -7.51 | 25.88 | 14.37 | 6.09 | -4.81 | |||||
Inventory, 1 Yr. Growth % | 15.71 | 12.25 | 0.59 | 30.79 | -5.91 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.66 | 1.82 | 3.67 | 1.97 | 2.63 | |||||
Total Assets, 1 Yr. Growth % | 4.01 | 1.85 | 3.41 | 1.18 | 1.31 | |||||
Tangible Book Value, 1 Yr. Growth % | 10.58 | 0.01 | -7.1 | -4.05 | 5.19 | |||||
Common Equity, 1 Yr. Growth % | 10.58 | 2.97 | -6.49 | -3.86 | 4.36 | |||||
Cash From Operations, 1 Yr. Growth % | -12.1 | 19.61 | 10.2 | -1.25 | -4.84 | |||||
Capital Expenditures, 1 Yr. Growth % | -1.87 | 10.15 | 19.1 | 6.94 | 12.05 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -28.48 | 51.93 | -0.25 | -7.27 | -15.15 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -23.74 | 40.22 | 0.18 | -4.89 | -12.15 | |||||
Dividend Per Share, 1 Yr. Growth % | 8.34 | 7.28 | 7.53 | 10 | 9.09 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -7.05 | 2.42 | 18.47 | 8.19 | -1.06 | |||||
Gross Profit, 2 Yr. CAGR % | -3.8 | 3.28 | 13.27 | 3.81 | -1.71 | |||||
EBITDA, 2 Yr. CAGR % | -3.8 | 3.28 | 13.27 | 3.81 | -1.71 | |||||
EBITA, 2 Yr. CAGR % | -5.41 | 3.47 | 16.1 | 3.15 | -3.43 | |||||
EBIT, 2 Yr. CAGR % | -5.41 | 3.47 | 16 | 3.06 | -3.54 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -8.59 | 6.54 | 22.75 | -0.88 | -8.16 | |||||
Net Income, 2 Yr. CAGR % | -8.59 | 6.54 | 22.75 | -0.88 | -8.16 | |||||
Normalized Net Income, 2 Yr. CAGR % | -7.75 | 3.73 | 19.41 | 3.61 | -4.56 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -3.18 | 9.94 | 27.48 | 4.94 | -3.46 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.98 | 7.9 | 19.99 | 10.16 | 0.49 | |||||
Inventory, 2 Yr. CAGR % | 7.16 | 13.97 | 6.26 | 14.7 | 10.19 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 1.42 | 1.24 | 2.74 | 2.82 | 1.99 | |||||
Total Assets, 2 Yr. CAGR % | 4.09 | 2.93 | 2.63 | 2.29 | 1.01 | |||||
Tangible Book Value, 2 Yr. CAGR % | 2.12 | 4.91 | -3.61 | -5.59 | -0.18 | |||||
Common Equity, 2 Yr. CAGR % | 2.12 | 6.7 | -1.87 | -5.18 | -0.45 | |||||
Cash From Operations, 2 Yr. CAGR % | -4.16 | 2.53 | 14.81 | 4.32 | -2.56 | |||||
Capital Expenditures, 2 Yr. CAGR % | -3.47 | 3.96 | 14.53 | 12.85 | 9.4 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -12.85 | 5.6 | 23.25 | -3.82 | -10.85 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -9.46 | 4.57 | 18.63 | -2.39 | -8.2 | |||||
Dividend Per Share, 2 Yr. CAGR % | 8.72 | 13.46 | 6.9 | 9.05 | 9.54 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -2.47 | 0.73 | 7.56 | 11.47 | 5.11 | |||||
Gross Profit, 3 Yr. CAGR % | 4.26 | 1.99 | 5.87 | 7.57 | 2.07 | |||||
EBITDA, 3 Yr. CAGR % | 4.26 | 1.99 | 5.87 | 7.57 | 2.07 | |||||
EBITA, 3 Yr. CAGR % | 5.12 | 1.94 | 6.54 | 8.35 | 1.23 | |||||
EBIT, 3 Yr. CAGR % | 5.12 | 1.94 | 6.48 | 8.29 | 1.15 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -20.35 | 4.54 | 7.74 | 10.35 | -2.82 | |||||
Net Income, 3 Yr. CAGR % | -20.35 | 4.54 | 7.74 | 10.35 | -2.82 | |||||
Normalized Net Income, 3 Yr. CAGR % | 1.79 | 1.43 | 7.42 | 10.03 | 1.09 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -15.61 | 9.49 | 11.95 | 15.52 | 2.13 | |||||
Accounts Receivable, 3 Yr. CAGR % | -2.03 | 4.36 | 10.02 | 15.16 | 4.92 | |||||
Inventory, 3 Yr. CAGR % | -6.71 | 8.83 | 9.32 | 13.88 | 6.89 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 1.19 | 1.56 | 2.04 | 2.49 | 2.55 | |||||
Total Assets, 3 Yr. CAGR % | 3.65 | 3.34 | 3.09 | 2.14 | 1.8 | |||||
Tangible Book Value, 3 Yr. CAGR % | -3.78 | 1.25 | 0.74 | -3.76 | -2.54 | |||||
Common Equity, 3 Yr. CAGR % | -3.78 | 2.4 | 2.11 | -2.54 | -2.5 | |||||
Cash From Operations, 3 Yr. CAGR % | 7.08 | 3.19 | 5.03 | 9.19 | 0.96 | |||||
Capital Expenditures, 3 Yr. CAGR % | -7.28 | 0.87 | 8.78 | 11.94 | 12.19 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 5.69 | 4.46 | 3.69 | 12.1 | -7.69 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 6.76 | 4.42 | 3.15 | 10.21 | -5.7 | |||||
Dividend Per Share, 3 Yr. CAGR % | 10.07 | 8.37 | 11.32 | 7.93 | 9.06 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -2.17 | 2.5 | 5.42 | 3.65 | 4.02 | |||||
Gross Profit, 5 Yr. CAGR % | 3.83 | 7.44 | 7.64 | 2.74 | 2.58 | |||||
EBITDA, 5 Yr. CAGR % | 3.83 | 7.44 | 7.64 | 2.74 | 2.58 | |||||
EBITA, 5 Yr. CAGR % | 4.18 | 9.36 | 9.21 | 2.46 | 2.16 | |||||
EBIT, 5 Yr. CAGR % | 4.18 | 9.36 | 9.17 | 2.42 | 2.11 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 7.04 | 17.14 | -5.3 | 2.34 | 0.82 | |||||
Net Income, 5 Yr. CAGR % | 7.04 | 17.14 | -5.3 | 2.34 | 0.82 | |||||
Normalized Net Income, 5 Yr. CAGR % | 3.31 | 9.6 | 8.3 | 2.34 | 2.18 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.47 | 22.75 | -0.47 | 7.64 | 5.18 | |||||
Accounts Receivable, 5 Yr. CAGR % | -1.47 | 4.12 | 6.24 | 6.64 | 6.1 | |||||
Inventory, 5 Yr. CAGR % | -2.91 | -3.59 | -1.73 | 11.14 | 9.67 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 1.75 | 1.47 | 1.81 | 2.06 | 2.02 | |||||
Total Assets, 5 Yr. CAGR % | 2.75 | 2.74 | 3.24 | 2.92 | 2.25 | |||||
Tangible Book Value, 5 Yr. CAGR % | 2.48 | 2.34 | -3.8 | -1.55 | 0.37 | |||||
Common Equity, 5 Yr. CAGR % | 2.37 | 2.93 | -3.02 | -0.7 | 1.08 | |||||
Cash From Operations, 5 Yr. CAGR % | 4.81 | 10.89 | 10.11 | 3.64 | 1.59 | |||||
Capital Expenditures, 5 Yr. CAGR % | -8.69 | -5.67 | 0.9 | 5.5 | 8.82 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 16.97 | 48.44 | 12.12 | 1.11 | -2.55 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 14.35 | 33.8 | 11.15 | 1.68 | -1.68 | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.24 | 9.24 | 9 | 8.45 | 10.6 |
- Stock Market
- Equities
- CSX Stock
- Financials CSX Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition